Evaluation of Impaction Force of Nasal Sprays and Metered-Dose Inhalers Using the Texture Analyser

被引:7
|
作者
Guo, Changning [1 ]
Ye, Wei [1 ]
Kauffman, John [1 ]
Doub, William H. [1 ]
机构
[1] US FDA, Div Pharmaceut Anal, St Louis, MO 63101 USA
关键词
impaction force; nasal spray; MDI; Texture Analyser; design of experiment; PARAMETERS;
D O I
10.1002/jps.21648
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
The impaction force from an inhalation product is an important characteristics by which to characterize the spray plume. It is one of the plume characteristics that can be perceived by a patient, and is expected to be good measures of local delivery equivalence for inhalation drugs. A Stable Micro Systems TA-XT.plus Texture Analyser equipped with 750 g load cell was used to measure the impaction force of several nasal sprays and metered-dose inhalers (MDIs). A survey of several commercial nasal spray and MDI products shows that impaction forces of these products varies from 1.5 to 6.5 g force and are significantly different from each other. A 3-level, 4-factor Box-Behnken design was applied to the study of impaction force of nasal sprays using placebo solutions. The influences of four factors: actuation stroke length, actuation velocity, concentration of gelling agent, and concentration of surfactant, were investigated. Of those factors examined here, actuation velocity exerts the greatest effect on impaction force. Impaction force is a discriminative parameter for in vitro testing of nasal spray and MDI products. Since impaction force is more directly related to patient sensation and aerosol deposition in the nasal mucus than other, more traditional parameters, it may provide a better way to evaluate in vitro equivalence in support of abbreviated new drug applications (ANDAS) for orally inhaled and nasal drug products. (C) 2008 Wiley-Liss, Inc. and the American Pharmacists Association J Pharm Sci 98:2799-2806, 2009
引用
收藏
页码:2799 / 2806
页数:8
相关论文
共 50 条
  • [1] METERED-DOSE INHALERS - THE SPECIFIED NUMBER OF SPRAYS
    BERGNER, A
    GREISNER, WA
    BERGNER, RK
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1993, 269 (12): : 1506 - 1506
  • [2] Using metered-dose inhalers
    Moore, KA
    ANNALS OF EMERGENCY MEDICINE, 1996, 27 (02) : 271 - 272
  • [3] EVALUATION OF PHARMACEUTICAL METERED-DOSE INHALERS
    CHILDERS, AG
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 1989, 198 : 124 - ANYL
  • [4] METERED-DOSE INHALERS
    MOORE, A
    BRITISH MEDICAL JOURNAL, 1993, 307 (6917): : 1498 - 1498
  • [5] Using metered-dose inhalers - Reply
    Jones, JS
    ANNALS OF EMERGENCY MEDICINE, 1996, 27 (02) : 272 - 272
  • [6] METERED-DOSE INHALERS - COMMENT
    WILLIAMS, DM
    PLEASANTS, RA
    DICP-THE ANNALS OF PHARMACOTHERAPY, 1989, 23 (10): : 815 - 816
  • [7] METERED-DOSE INHALERS - COMMENT
    SELF, TH
    DICP-THE ANNALS OF PHARMACOTHERAPY, 1991, 25 (03): : 321 - 321
  • [8] Equivalence testing and equivalence limits of metered-dose inhalers and dry powder inhalers measured by in vitro impaction
    Weda, M
    Geuns, ERM
    Vermeer, RCR
    Buiten, NRA
    Hendriks-de Jong, K
    Bult, A
    Zanen, P
    Barends, DM
    EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS, 2000, 49 (03) : 295 - 302
  • [9] Compatibility of spacers with metered-dose inhalers
    Lakamp, RE
    Berry, TM
    Prosser, TR
    Baher, TD
    AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY, 2001, 58 (07) : 585 - 591
  • [10] THE CONTINUED NEED FOR METERED-DOSE INHALERS
    BOYD, G
    JOURNAL OF AEROSOL MEDICINE-DEPOSITION CLEARANCE AND EFFECTS IN THE LUNG, 1995, 8 : S9 - S12